N‐acetylcysteine as a treatment for substance use cravings: A meta‐analysis
Emma L Winterlind, Samantha G Malone, Michael R Setzer, Mikela A Murphy, David Saunders, Joshua C Gray · 2024
Read N‐acetylcysteine as a treatment for substance use cravings: A meta‐analysis by Emma L Winterlind, Samantha G Malone, Michael R Setzer, Mikela A Murphy, David Saunders, Joshua C Gray (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11572739.txt.
Description
N‐acetylcysteine (NAC) may serve as a novel pharmacotherapy for substance use and substance craving in individuals with substance use disorders (SUDs), possibly through its potential to regulate glutamate. Though prior meta‐analyses generally support NAC's efficacy in reducing symptoms of craving, individual trials have found mixed results.
Catalog record
| CREATOR | Emma L Winterlind, Samantha G Malone, Michael R Setzer, Mikela A Murphy, David Saunders, Joshua C Gray |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |